PROTEIN-OVERLOADING PARALYSIS
Interestingly, the dual agonist tirzepatide has shown efficacy in neuroprotection, by counteracting hyperglycemia and insulin resistance-related effects at the neuronal level (Fontanella et al., 2024)
Here are the states with the most GLP-1 prescriptions: Kentucky (20.7 prescriptions dispensed per 1,000 people) West Virginia (18.9 prescriptions dispensed per 1,000 people) Alaska (17.5 prescriptions dispensed per 1,000 people) Mississippi (16.1 prescriptions dispensed per 1,000 people) Louisiana (15.4 prescriptions dispensed per 1,000 people) The data is based on a collection of 1.9 billion claims from private insurers, as well as Medicare which only covers GLP-1s to treat diabetes and Medicaid, said Axios
Diabetes Ther 9 , 877890 (2018)
Participants reported improvements in mobility, physical activity capacity, and energy levels throughout treatment despite substantial weight reduction
The association between symptoms and ammonia concentration remains unclear, with a significant proportion of individuals with HA cases remaining apparently asymptomatic
